LPX vs PFE · P/E 64, rev $1.24B vs P/E 20, rev $15.03B
Louisiana-Pacific Corporation (LPX) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Louisiana-Pacific Corporation (LPX) is a building products & equipment company listed on NYSE.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported LPX revenue for 2026-06-30 was $1.24B. Net income was $53.0M. LPX currently screens at market cap $5.26B and trailing P/E 64.4.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
LPX currently screens at market cap $5.26B and trailing P/E 64.4. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the LPX and PFE stock pages for the full models.
Not investment advice.